U.S. Physical Therapy (NYSE:USPH) Upgraded by Bank of America to “Buy” Rating

U.S. Physical Therapy (NYSE:USPH) was upgraded by equities research analysts at Bank of America from a “neutral” rating to a “buy” rating in a research note issued on Monday,Briefing.com Automated Import reports. The brokerage presently has a $115.00 price target on the stock, up from their previous price target of $100.00. Bank of America‘s price target points to a potential upside of 23.05% from the stock’s previous close.

Several other brokerages have also recently commented on USPH. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Tuesday, December 3rd. StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average price target of $114.00.

U.S. Physical Therapy Stock Down 0.6 %

NYSE:USPH opened at $93.46 on Monday. The stock has a 50-day simple moving average of $89.32 and a 200 day simple moving average of $89.89. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63. The company has a market cap of $1.41 billion, a PE ratio of 99.43, a PEG ratio of 4.23 and a beta of 1.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78.

Insider Transactions at U.S. Physical Therapy

In related news, Director Bernard A. Harris, Jr. sold 2,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $92.95, for a total value of $185,900.00. Following the transaction, the director now owns 16,726 shares in the company, valued at approximately $1,554,681.70. This represents a 10.68 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Nancy Ham sold 1,172 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the transaction, the director now directly owns 1,112 shares in the company, valued at approximately $107,552.64. This represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 7,412 shares of company stock worth $706,605. 1.70% of the stock is owned by company insiders.

Institutional Trading of U.S. Physical Therapy

Institutional investors have recently added to or reduced their stakes in the company. First Horizon Advisors Inc. lifted its holdings in shares of U.S. Physical Therapy by 18.6% during the second quarter. First Horizon Advisors Inc. now owns 1,188 shares of the company’s stock worth $110,000 after buying an additional 186 shares in the last quarter. Fifth Third Bancorp raised its stake in U.S. Physical Therapy by 41.4% in the 2nd quarter. Fifth Third Bancorp now owns 1,332 shares of the company’s stock worth $123,000 after purchasing an additional 390 shares in the last quarter. SG Americas Securities LLC boosted its holdings in U.S. Physical Therapy by 37.7% in the 2nd quarter. SG Americas Securities LLC now owns 5,924 shares of the company’s stock valued at $547,000 after purchasing an additional 1,623 shares during the period. BNP Paribas Financial Markets increased its holdings in shares of U.S. Physical Therapy by 283.0% during the third quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company’s stock worth $1,425,000 after purchasing an additional 12,445 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company’s stock valued at $223,000 after buying an additional 956 shares during the period.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.